Market Tracker

04/24 7:02am ET

SPDR S&P Biotech ETF (XBI)

Data as of Apr 23
 -3.72 / -2.77%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-12.27% 3 years+23.34%
3 months-15.71% 5 years+25.24%
1 year+26.45% Since inception+13.18%
Data through 04/23/2014

Quote Details

Previous close$134.09
Open day’s range-- – --
Net asset value (NAV)134.22 (04/22/2014)
Daily volume789,392
Average volume (3 months)783,617
Data as of 04/23/2014

Peer Comparisonvs. Health ETFs

Performance 5-yr return+25.24%+25.56%
Expense Gross exp ratio0.35%0.43%
Risk 5 year sharpe ratio1.031.59
Net assets$1.3B$1.3B
Average market cap$1.8B$31.7B
Average P/E--26.8
Dividend / Share--0.20%


VHT Vanguard Health Care ETF
RYH Guggenheim S&P 500® Equal Weight Health...
XLV Health Care Select Sector SPDR® Fund


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GERN Geron Corporation1.54%
KERX Keryx Biopharmaceuticals, Inc.1.53%
EXAS Exact Sciences Corporation1.47%
ITMN InterMune, Inc.1.41%
ACOR Acorda Therapeutics, Inc.1.38%
AMGN Amgen Inc1.36%
DNDN Dendreon Corp1.35%
ACHN Achillion Pharmaceuticals, Inc.1.35%
INSM Insmed, Inc.1.34%
UTHR United Therapeutics Corporation1.34%